- Home
- IDYA vs MANU Comparison
IDYA vs MANU Comparison
Compare IDYA & MANU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- MANU
- Stock Information
- Founded
- IDYA 2015
- MANU 1878
- Country
- IDYA United States
- MANU United Kingdom
- Employees
- IDYA N/A
- MANU N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- MANU Services-Misc. Amusement & Recreation
- Sector
- IDYA Health Care
- MANU Consumer Discretionary
- Exchange
- IDYA Nasdaq
- MANU Nasdaq
- Market Cap
- IDYA 1.9B
- MANU 2.2B
- IPO Year
- IDYA 2019
- MANU 2012
- Fundamental
- Price
- IDYA $21.23
- MANU $17.77
- Analyst Decision
- IDYA Strong Buy
- MANU Buy
- Analyst Count
- IDYA 13
- MANU 2
- Target Price
- IDYA $53.42
- MANU $20.75
- AVG Volume (30 Days)
- IDYA 1.1M
- MANU 440.3K
- Earning Date
- IDYA 08-05-2025
- MANU 06-06-2025
- Dividend Yield
- IDYA N/A
- MANU N/A
- EPS Growth
- IDYA N/A
- MANU N/A
- EPS
- IDYA N/A
- MANU N/A
- Revenue
- IDYA $7,000,000.00
- MANU $832,748,485.00
- Revenue This Year
- IDYA $101.20
- MANU $2.44
- Revenue Next Year
- IDYA $286.70
- MANU $3.26
- P/E Ratio
- IDYA N/A
- MANU N/A
- Revenue Growth
- IDYA N/A
- MANU N/A
- 52 Week Low
- IDYA $13.45
- MANU $12.05
- 52 Week High
- IDYA $44.42
- MANU $19.65
- Technical
- Relative Strength Index (RSI)
- IDYA 62.23
- MANU 67.24
- Support Level
- IDYA $21.08
- MANU $17.30
- Resistance Level
- IDYA $22.37
- MANU $19.65
- Average True Range (ATR)
- IDYA 0.92
- MANU 0.84
- MACD
- IDYA -0.09
- MANU 0.16
- Stochastic Oscillator
- IDYA 61.72
- MANU 73.86
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
About MANU Manchester United Ltd.
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, and sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which the majority of the revenue is generated including Commercial, Broadcasting, and Matchday.